Clinical Trial Update: A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effects of Omaveloxolone (RTA 408) in youths and adults aged 16 to 40 with Friedreich's Ataxia has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Omaveloxolone (omaveloxolone)

Snippet

Sponsor: Biogen | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED | Results posted: 2022-11-29